CHROMADEX ($CDXC) is expected to release its quarterly earnings data on Tuesday, March 4th after market close, per Finnhub. Analysts are expecting revenue of $27,267,996 and earnings of $0.02 per share.
You can see Quiver Quantitative's $CDXC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHROMADEX Insider Trading Activity
CHROMADEX insiders have traded $CDXC stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CDXC stock by insiders over the last 6 months:
- FRANK L JR JAKSCH sold 37,161 shares for an estimated $229,955
- OZAN PAMIR (Chief Financial Officer) purchased 2,907 shares for an estimated $21,396
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CHROMADEX Hedge Fund Activity
We have seen 74 institutional investors add shares of CHROMADEX stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. added 957,665 shares (+1785.9%) to their portfolio in Q4 2024, for an estimated $5,080,412
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 492,148 shares (+288.1%) to their portfolio in Q4 2024, for an estimated $2,610,845
- TIETON CAPITAL MANAGEMENT, LLC removed 367,506 shares (-12.4%) from their portfolio in Q4 2024, for an estimated $1,949,619
- QUBE RESEARCH & TECHNOLOGIES LTD added 346,918 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,840,399
- CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. added 331,014 shares (+189.0%) to their portfolio in Q4 2024, for an estimated $1,756,029
- CUBIST SYSTEMATIC STRATEGIES, LLC added 310,369 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,646,507
- STATE STREET CORP added 296,947 shares (+48.0%) to their portfolio in Q4 2024, for an estimated $1,575,303
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
